utilities

Archive | Funding

Exciting new phase in the UK Dementia Research Institute

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

In May 2016 we committed £50m to support the UK Dementia Research Institute (UK DRI), our biggest financial commitment to a single initiative in our 25-year history. After an international search, Prof Bart De Strooper was named as Director of the UK DRI in late 2016, and UCL was announced as the hub of the […]

How do we decide which studies to fund?

Fred Walker

Twice a year, the Alzheimer’s Research UK Grant Review Board meets to assess potential new grants. We get many grant applications each year from researchers looking for funding for their studies. The Grant Review Board exists to make sure we’re funding the most promising, practical and cost-effective studies, that will bring us closer to beating […]

Read more

UK’s biggest dementia research endeavour starts to take shape

Hilary Evans

Today we’re proud to share with you the news that world-renowned Belgian scientist Prof Bart De Strooper will take the helm of the UK Dementia Research Institute (DRI), a multi-centre national Institute being created to transform the landscape of dementia research in this country. It’s been several months since we announced our commitment of £50m […]

Read more

New report recommends plan for Government to accelerate access to new medicines at ‘crucial time’ for dementia

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

Today sees the publication of the final report of the Accelerated Access Review, which seeks to accelerate access to all new innovations, including drugs, diagnostics and medical technologies.  The recommendations of this review will be critical in addressing the challenges new dementia treatments are likely to face and will set the scene for access to […]

Using computers to decode Alzheimer’s and Parkinson’s

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

It might sound like something from a science fiction movie but computers are telling us more and more about the human brain and how it works. In 2013, the European Commission launched a multi-million pound Human Brain Project (HBP) with the goal of integrating work from multiple research teams to create a supercomputer simulation of […]

Walking 100k to raise £100k

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

This September 200 of our supporters will Race the Tide in a tough 30 hour non-stop hike through the Northumbrian countryside. Their willpower and determination will raise an amazing £100,000 to defeat dementia. So what exactly can Alzheimer’s Research UK achieve with £100,000? Uniting experts to unravel genetics Thanks to £100,000 fundraised by staff at […]

Tagged with:

How do we fund research?

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

As the UK’s leading dementia research charity, we receive requests for funding from researchers all over the country; last year we committed £7.6 million to pioneering dementia research. Project proposals range from unravelling the genetics of frontotemporal dementia in flies to taking a closer look at the human brain in Alzheimer’s with sophisticated scanners. As […]

Rules and regulations: removing hurdles in the race for a treatment

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

When we talk about speeding up drug development, the image that probably springs to mind is a lab full of scientists in white coats, working hard on the problem at hand. Most people won’t think of rows of MPs in the House of Commons, yet our politicians have a big part to play in the […]

The Global Clinical Trials Fund: drugs and dummies

Kirsty MaraisClare van LyndenSusan MitchellEmily CookEmma HardwickHelen Davies

Today marks one year since the G8 Dementia Summit. The last year has been a whirlwind of new investment and exciting initiatives, both from Alzheimer’s Research UK and government, all with one aim: to bring us closer to a treatment for dementia. But we mustn’t lose momentum. Today, we are pleased to announce our newest […]